Ascending single dose study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of SRA-444 administered orally to healthy adult subjects
Phase of Trial: Phase I
Latest Information Update: 18 Jan 2010
At a glance
- Drugs SRA 444 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 05 Jun 2007 New trial record.